Cytovance Biologics, Inc., Oklahoma City, Oklahoma-based contract manufacturing organization of mammalian and microbial biologics, received a $20m senior credit facility.
Monroe Capital provided the financing.
The company intends to use the funds to continue to grow operations.
Cytovance works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. The company supports its customers from clinical development to commercial launch in domestic and international markets.